EMERYVILLE, Calif. — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and the Jaime Leandro Foundation for Therapeutic Cancer Vaccines (JLF), today announced the discovery, functional characterization, and recovery of a patient-derived T cell receptor sequence against a cancer neoantigen. Together, Berkeley Lights and JLF were able to measure and identify T cells […]

$76 million investment increases the site’s capacity to produce critical raw materials used in the development and manufacturing of vaccines and biologic therapies GRAND ISLAND, N.Y. – To meet increasing global demand for cell culture media used in the manufacturing of new vaccines and biologics, Thermo Fisher Scientific has expanded its dry powder media manufacturing facility […]

COLUMBIA, Md. — Shimadzu Scientific Instruments and PACE Analytical Services have developed an alternate test procedure (ATP) to EPA Method 1613B—PAM-16130-SSI: Determination of 2,3,7,8-Substituted Tetra- through Octa-Chlorinated Dibenzo-p-Dioxins and Dibenzofurans (CDDs/CDFs) Using Shimadzu Gas Chromatography Mass Spectrometry (GC-MS/MS). This ATP allows the use of GC-MS/MS in place of high-resolution mass spectrometry (GC/HRMS) for the determination of […]

– FDA EUA Variant Calling Assay Allows for Sequencing to Inform Patient Treatment – SOUTH SAN FRANCISCO, Calif. & NEW YORK — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Biotia, Inc., a company that uses proprietary analytical software for […]

UK facility adds significant resources to address demand for recombinant antibodies Redcar, UK. Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the near doubling of its manufacturing facility in northeast England. The increased laboratory space includes a major investment in new automation for Next Generation Sequencing (NGS), expression and purification […]

Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tool for the job will build a new, expanded campus right around the corner from its current headquarters in Pleasanton, CA. Unchained entered into a very long-term (basically forever) lease on a 12-acre property at […]

BOSTON, Mass. — TetraScience, the Scientific Data Cloud Company, is pleased to share its 2022 year-to-date highlights, including 111% annual recurring revenue (ARR) growth, 400% growth in the Tetra Partner Network, product and category expansion, and continued operational excellence and capital efficiency. TetraScience is reiterating its full-year 2022 guidance of 123% ARR growth and 400% […]

NEW YORK, N.Y. – New Mountain Capital, a growth-oriented investment firm with over $37 billion in assets under management, today announced that it has entered into a definitive agreement with the intention to acquire PerkinElmer’s Applied, Food and Enterprise Services businesses, a carve-out from the Discovery & Analytical Solutions segment of PerkinElmer, Inc. (NYSE: PKI), […]

Enters agreement with intention to divest Applied, Food and Enterprise Services businesses WALTHAM, Mass. — PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced it has entered into an agreement with the intention to divest its Applied, Food and Enterprise Services businesses to New Mountain Capital, a leading growth-oriented […]

Marking its 20th global recipient, the grant program supports next-generation sequencing-based research to explore new and expanded applications for molecular testing CARLSBAD, Calif. – As part of its continued commitment to expand the benefits of next-generation sequencing (NGS), Thermo Fisher Scientific is now accepting submissions for the fifth round of the Oncomine Clinical Research Grant program. […]